Wells Fargo & Company Pds Biotechnology Corp Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Wells Fargo & Company holds 5,329 shares of PDSB stock, worth $7,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,329

Previous 4,829 10.35%

Holding current value

$7,087

Previous $7,000 14.29%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$1.18 - $1.8 $590 - $900	500 Added 10.35%	5,329 $6,000
Q4 2024 Feb 12, 2025	BUY	$1.63 - $4.11 $163 - $411	100 Added 2.11%	4,829 $7,000
Q3 2024 Nov 13, 2024	BUY	$2.93 - $4.23 $3,600 - $5,198	1,229 Added 35.11%	4,729 $18,000
Q2 2024 Aug 13, 2024	SELL	$2.55 - $4.02 $17,821 - $28,095	-6,989 Reduced 66.63%	3,500 $10,000
Q1 2024 May 10, 2024	BUY	$3.85 - $6.59 $12,412 - $21,246	3,224 Added 44.38%	10,489 $41,000
Q4 2023 Feb 09, 2024	BUY	$3.95 - $6.58 $5,127 - $8,540	1,298 Added 21.75%	7,265 $36,000
Q3 2023 Nov 13, 2023	SELL	$4.8 - $6.4 $54,115 - $72,153	-11,274 Reduced 65.39%	5,967 $30,000
Q2 2023 Aug 15, 2023	BUY	$5.03 - $9.9 $59,560 - $117,225	11,841 Added 219.28%	17,241 $86,000
Q1 2023 May 12, 2023	SELL	$5.68 - $11.99 $113,281 - $239,128	-19,944 Reduced 78.69%	5,400 $33,000
Q4 2022 Feb 13, 2023	SELL	$3.28 - $13.2 $1,213 - $4,884	-370 Reduced 1.44%	25,344 $334,000
Q3 2022 Nov 14, 2022	BUY	$2.97 - $5.79 $75,877 - $147,922	25,548 Added 15390.36%	25,714 $77,000
Q2 2022 Aug 12, 2022	BUY	$3.05 - $6.68 $42 - $93	14 Added 9.21%	166 $1,000
Q4 2021 Feb 14, 2022	BUY	$7.76 - $14.35 $38 - $71	5 Added 3.4%	152 $1,000
Q3 2021 Nov 15, 2021	BUY	$9.33 - $17.08 $223 - $409	24 Added 19.51%	147 $2,000
Q2 2021 Aug 16, 2021	SELL	$4.35 - $12.86 $4 - $12	-1 Reduced 0.81%	123 $2,000
Q1 2021 May 13, 2021	SELL	$2.28 - $6.81 $2 - $6	-1 Reduced 0.8%	124 $1,000
Q4 2020 Feb 09, 2021	BUY	$1.91 - $2.67 $97 - $136	51 Added 68.92%	125 $0
Q2 2020 Aug 13, 2020	SELL	$0.65 - $2.6 $0 - $2	-1 Reduced 1.33%	74 $0
Q1 2020 May 14, 2020	BUY	$0.67 - $3.04 $50 - $228	75 New	75 $0

Others Institutions Holding PDSB

# of Institutions

Shares Held

8.24M

Call Options Held

151K

Put Options Held

1.2K

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $37.9M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Pds Biotechnology Corp Transaction History